Related Experiment Videos
Neurite degeneration elicited by apolipoprotein E peptides
K A Crutcher1, M A Clay, S A Scott
1Department of Neurosurgery, University of Cincinnati Medical Center, Ohio 45267-0515.
Experimental Neurology
|November 1, 1994
Summary
Apolipoprotein E (apoE) peptides, particularly the E141-155 sequence, induce neurite degeneration in vitro. This suggests apoE fragments may directly contribute to neurodegenerative diseases like Alzheimer's disease (AD).
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Apolipoprotein E (apoE) is found in Alzheimer's disease (AD) brain lesions.
- Specific apoE sequences have shown cytotoxicity to lymphocytes in culture.
Purpose of the Study:
- To investigate the neurotoxic potential of specific Apolipoprotein E (apoE) peptide sequences.
- To explore the role of apoE in neurodegenerative processes.
Main Methods:
- Utilized in vitro models with embryonic chick sympathetic ganglia.
- Synthesized and applied tandem and monomeric apoE peptides (E141-155 domain).
- Observed neurite degeneration and beta A4/apoE binding.
Main Results:
- Tandem and longer apoE peptides (E141-155) caused specific and extensive neurite degeneration.
- Demonstrated strong in vitro binding between beta A4 and apoE.
- Noted the epsilon 4 allele's disproportionate occurrence in AD patients.
Conclusions:
- Specific Apolipoprotein E (apoE) peptide sequences may directly drive neurodegeneration.
- Findings support a role for apoE in the pathogenesis of Alzheimer's disease (AD).